Method for Improved Intraoperative Blood Loss Estimates
NCT ID: NCT01634828
Last Updated: 2016-05-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
47 participants
OBSERVATIONAL
2012-07-31
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Estimated Blood Loss: Novel Model for Estimating Surgical Blood Loss.
NCT03249038
Blood Loss Quantification During Major Abdominal Surgery
NCT05316649
Phlebotomy to Prevent Blood Loss in Major Hepatic Resections
NCT02548910
Perioperative Blood Transfusion in Open Liver Resection
NCT06189911
Intra-operative Monitoring of Blood Loss
NCT01864980
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Minimal blood loss patients
No interventions assigned to this group
Moderate to heavy blood loss patients
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. Pregnant women
3. Prisoners
4. Lack of informed consent
5. Attending Physician feels enrollment could interfere with optimal patient care
6. Patients who did not have a preoperative hemoglobin measured as part of their preoperative work-up
7. Patients whose preoperative hemoglobin fraction is abnormal.
8. Patients who will likely require an intraoperative blood transfusion.
9. Patients for whom the intraoperative use of the Cell Saver is anticipated.
18 Years
100 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Utah
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Annette Macintyre
Principle Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Utah
Salt Lake City, Utah, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
56181
Identifier Type: REGISTRY
Identifier Source: secondary_id
FP00002762
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.